StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories smelters Committed to or Actively Undergoing RMAP Audit

Form SD Specialized Disclosure Reports (FY2014–FY2025)

Latest, FY2025
7
Period ended Dec 31, 2025
Change on a year earlier
-12.5%
8 in FY2024
History
12 years
Since FY2014
Sources
12
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSmelters Committed to or Actively Undergoing RMAP AuditYear on yearSource
FY2025Dec 31, 20257-12.5%SEC Filing (0001104659-26-066986) ↗
FY2024Dec 31, 20248-20.0%SEC Filing (0000001800-25-000006) ↗
FY2023Dec 31, 202310-23.1%SEC Filing (0001104659-24-066637) ↗
FY2022Dec 31, 202213-38.1%SEC Filing (0001104659-23-066523) ↗
FY2021Dec 31, 202121-4.5%SEC Filing (0001104659-22-065888) ↗
FY2020Dec 31, 202022+340.0%SEC Filing (0001104659-21-073673) ↗
FY2019Dec 31, 20195-16.7%SEC Filing (0001104659-20-067425) ↗
FY2018Dec 31, 20186-60.0%SEC Filing (0001104659-19-033008) ↗
FY2017Dec 31, 201715+7.1%SEC Filing (0001104659-18-037140) ↗
FY2016Dec 31, 201614-68.9%SEC Filing (0001104659-17-036399) ↗
FY2015Dec 31, 201545-13.5%SEC Filing (0001104659-16-124278) ↗
FY2014Dec 31, 201452–SEC Filing (0001104659-15-041939) ↗

Cite this data

StockData. (2026). Abbott Laboratories Smelters Committed to or Actively Undergoing RMAP Audit, annual FY2014–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/sd-active-audit

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.